1. Abuse-deterrent opioid formulations: Are they a pipe dream?
2. Update on Abuse-Resistant and Abuse-Deterrent Approaches to Opioid Formulations
3. Opioid Formulations Designed to Resist/Deter Abuse
4. FDA, Guidance for Industry. Dissolution Testing of Immediate Release Solid Oral Dosage Forms. Rockville, MD: U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), 1997.
5. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Guideline Q 1 A (R2): Stability testing of new drug substances and products. Geneva, Switzerland: International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use, 2003.